Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration.

Authors

null

Anthony Frank Shields

Karmanos Cancer Institute, Wayne State University, Detroit, MI

Anthony Frank Shields , Fang-Shu Ou , James Paul , Alberto F. Sobrero , Takayuki Yoshino , Julien Taieb , Ioannis Souglakos , Qian Shi , Rachel Kerr , Roberto Labianca , Takeharu Yamanaka , Dewi Vernerey , Ioannis Boukovinas , Takeshi Kato , Valter Torri , Stylianos Kakolyris , Thierry Andre , Axel Grothey , Jeffrey A. Meyerhardt , Timothy Iveson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT01150045

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3599)

DOI

10.1200/JCO.2018.36.15_suppl.3599

Abstract #

3599

Poster Bd #

92

Abstract Disclosures

Similar Posters

First Author: Toshiaki Shichinohe

Poster

2016 Gastrointestinal Cancers Symposium

“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.

“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.

First Author: Jy Ming Chiang

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.

Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.

First Author: Daniel Walden